FBIN vs REGN · P/E 16, rev $4.61B vs P/E 14, rev $14.34B
Fortune Brands Innovations Inc. (FBIN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Fortune Brands Innovations Inc. (FBIN) is a building products & equipment company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported FBIN revenue for 2024-12-28 was $4.61B. Net income was $471.9M. Revenue was down 0.4% from 2023-12-30 to 2024-12-28. FBIN currently screens at market cap $6.39B and trailing P/E 15.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
FBIN currently screens at market cap $6.39B and trailing P/E 15.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the FBIN and REGN stock pages for the full models.
Not investment advice.